Return to homepagePandemic Pact

ANTI-COVID19: Functional protective antibody determinants during and after SARS-CoV-2 (and other CoV) infection to define and predict individual post- infection immunity, flock immunity and guide blood bank sero-treatment.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $516,160

  • Funder

    UFM Denmark

  • Principal Investigator

    Professor Anders Fomsgaard

  • Research Location

    Denmark

  • Lead Research Institution

    Statens Serum Institut

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project concerns immunity, hereunder the possibility to examine specific antibodies generated by COVID-19 patients during and after the disease (both severe and mild cases). The project aims to examine whether those antibodies produced in patients during COVID-19 may boost immunity in new patients or patients in risk groups and in this way support the treatment of the next wave of COVID patients